These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10647247)

  • 1. Polypharmacy. Reducing adverse events among the elderly in NJ.
    Hare GT; Reinhard SC; Brick JH; Tepper C; Zanna MT
    N J Med; 2000 Jan; 97(1):29-34. PubMed ID: 10647247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypharmacy. Reducing adverse events among the elderly in NJ. Part 1.
    Hare GT; Reinhard SC; Brick JH; Tepper C; Zanna MT
    N J Med; 1999 Dec; 96(12):35-8. PubMed ID: 10645137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting.
    Zarowitz BJ; Stebelsky LA; Muma BK; Romain TM; Peterson EL
    Pharmacotherapy; 2005 Nov; 25(11):1636-45. PubMed ID: 16232025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacy in the elderly: maximizing benefit, minimizing harm.
    Ballentine NH
    Crit Care Nurs Q; 2008; 31(1):40-5. PubMed ID: 18316935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug events in the elderly population admitted to a tertiary care hospital.
    Azad N; Tierney M; Victor G; Kumar P
    J Healthc Manag; 2002; 47(5):295-305; discussion 305-6. PubMed ID: 12325252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagramming patients' views of root causes of adverse drug events in ambulatory care: an online tool for planning education and research.
    Brown M; Frost R; Ko Y; Woosley R
    Patient Educ Couns; 2006 Sep; 62(3):302-15. PubMed ID: 16879943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice guidelines: development, application to clinical care, and role in provider education.
    Kiser JJ
    Clin Pharmacol Ther; 2009 Sep; 86(3):239-41. PubMed ID: 19707214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of information technology in improving medical performance. Part I. Information systems for medical transactions.
    Gawande AA; Bates DW
    MedGenMed; 2000 Feb; 2(1):E14. PubMed ID: 11104460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pitfalls of polypharmacy, particularly in the elderly].
    Queneau P
    Bull Mem Acad R Med Belg; 2006; 161(6):408-21; discussion 422-4. PubMed ID: 17288274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prescription to elderly patients: reducing underuse and adverse drug reactions and improving adherence].
    Legrain S
    Bull Acad Natl Med; 2007 Feb; 191(2):259-69; discussion 269-70. PubMed ID: 17969547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.
    Ness J; Hoth A; Barnett MJ; Shorr RI; Kaboli PJ
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):42-51. PubMed ID: 16730620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
    Sokol KC; Knudsen JF; Li MM
    J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people.
    Garfinkel D; Zur-Gil S; Ben-Israel J
    Isr Med Assoc J; 2007 Jun; 9(6):430-4. PubMed ID: 17642388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy in the Older Patient With Cancer.
    Corcoran ME
    Cancer Control; 1997 Oct; 4(5):419-428. PubMed ID: 10763050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing medication errors and increasing patient safety: case studies in clinical pharmacology.
    Benjamin DM
    J Clin Pharmacol; 2003 Jul; 43(7):768-83. PubMed ID: 12856392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy trends in office visits by the elderly in the United States, 1990 and 2000.
    Aparasu RR; Mort JR; Brandt H
    Res Social Adm Pharm; 2005 Sep; 1(3):446-59. PubMed ID: 17138489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy: a new paradigm for quality drug therapy in the elderly?
    Gurwitz JH
    Arch Intern Med; 2004 Oct; 164(18):1957-9. PubMed ID: 15477428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.